📰 Full Story
A parliamentary report published on June 3 by the House of Commons Science, Innovation and Technology Committee said Britain’s growing dependence on US data firm Palantir represents an “unacceptable point of weakness” for public services.
MPs urged ministers to consider exercising a break clause in Palantir’s NHS Federated Data Platform contract (awarded in 2023 and valued at about £330 million) and to explore UK-based alternatives.
The committee warned of vendor lock-in, resilience and national security risks from concentrating sensitive systems on a single overseas supplier, noted concerns about the company’s political links and public comments by co-founder Peter Thiel and CEO Alex Karp, and cited Palantir’s wider presence across defence, policing and regulation.
Palantir has defended the NHS programme as delivering benefits; its UK chief Louis Mosley called calls to cancel the deal “frankly irresponsible.” Campaigners, some NHS staff and London city officials have also raised procurement and data-access questions.
The committee recommended tighter digital strategy leadership and greater scrutiny of contracts with foreign tech providers.
🔗 Based On
🤝 Social Media Insights
Social Summary
Reporting and a BMJ article add credible health‑sector scrutiny to MPs’ national‑security concerns about Palantir, strengthening calls to consider cancelling the NHS contract and seek UK alternatives. Some commenters’ specific operational claims lack independent verification.







💬 Commentary